Conference call interim report
Invitation to attend Vitrolife’s conference call regarding presentation of the interim report for the period January – June 2016. The presentation will be held in English.
Time: Friday July 15, 2016 at 10.00 a.m. CET.
Registration can preferably be done 10-15 minutes before the conference start time on:
Sweden dial in number: +46 (0)8 5052 0110
UK dial in number: +44 (0)20 7162 0077
Conference name: Vitrolife, conference ID: 959489
Thomas Axelsson, CEO
Mikael Engblom, CFO
The press release for Vitrolife’s interim report will be released at 8.30 CET on the same day.
Before the conference call, slides will be available at the company web page, http://www.vitrolife.com
A recorded version of the presentation will be available for seven days on number
+46 (0)8 5052 0333 (Sweden) or 020 7031 4064 (UK), access code 959489.
Gothenburg, July 7, 2016
VITROLIFE AB (publ)
For further information, please contact:
Mikael Engblom, CFO, 46 (0) 31 721 80 14
This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.
Vitrolife is an international medical device Group. Vitrolife develops, produces and markets medical devices for assisted reproduction. Work is also carried out to enable the use and handling of stem cells for therapeutic purposes
Vitrolife has approximately 360 employees and the company's products are sold in almost 110 markets. The company is headquartered in Gothenburg, Sweden, and there are also offices in USA, Australia, France, Italy, United Kingdom, China, Japan, Hungary, Denmark and Germany. The Vitrolife share is listed on NASDAQ Stockholm, Mid Cap.
Vitrolife AB (publ), Box 9080, SE-400 92 Göteborg, Sweden. Corporate identity number 556354-3452. Tel: 46 31 721 80 00. Fax: 46 31 721 80 99. E-mail: email@example.com. Website: www.vitrolife.com/